Short-term pulmonary and systemic effects of hydrocortisone initiated 7-14 days after birth in ventilated very preterm infants

Autor: Nienke M, Halbmeijer, Wes, Onland, Filip, Cools, Andre, Kroon, Marja, van der Heide-Jalving, Peter, Dijk, Henrica L M, van Straaten, Arjan B, Te Pas, Thilo, Mohns, Els, Bruneel, Arno F J, van Heijst, Boris, Kramer, Anne, Debeer, Inge A, Zonnenberg, Yoann, Marechal, Henry, Blom, Katleen, Plaskie, Maruschka P, Merkus, Martin, Offringa, Anton H, van Kaam, Elke, Dierckx

Publikováno v: Archives of Disease in Childhood-Fetal and Neonatal Edition, 108(1), F20-F25. BMJ Publishing Group
Archives of Disease in Childhood-fetal and Neonatal Edition, 108(1), F20-F25. BMJ Publishing Group
Archives of disease in childhood. Fetal and neonatal edition, 108(1), F20-F25. BMJ Publishing Group
ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 108(1). BMJ PUBLISHING GROUP
Archives of Disease in Childhood: Fetal and Neonatal Edition, 108(1), F20-F25. BMJ Publishing Group
Archives of disease in childhood : fetal and neonatal edition
Halbmeijer, N M, Onland, W, Cools, F, Kroon, A, van der Heide-Jalving, M, Dijk, P, van Straaten, H L M, Te Pas, A B, Mohns, T, Bruneel, E, van Heijst, A F J, Kramer, B, Debeer, A, Zonnenberg, I A, Marechal, Y, Blom, H, Plaskie, K, Merkus, M P, Offringa, M, van Kaam, A H & SToP-BPD Study Group 2022, ' Short-term pulmonary and systemic effects of hydrocortisone initiated 7-14 days after birth in ventilated very preterm infants : a secondary analysis of a randomised controlled trial ', Archives of Disease in Childhood-Fetal and Neonatal Edition, vol. 108, no. 1, pp. F20-F25 . https://doi.org/10.1136/archdischild-2022-323882

ObjectiveObservational studies in preterm infants suggest that systemic hydrocortisone improves pulmonary condition but may also lead to systemic adverse effects. We report the short-term pulmonary and systemic effects of hydrocortisone initiated in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1b785d6e0d3fe2794a1a78f4342f8fd
http://www.scopus.com/inward/record.url?scp=85144416239&partnerID=8YFLogxK

The Effect of Systemic Hydrocortisone Initiated 7 to 14 Days After Birth in Ventilated Preterm Infants on Mortality and Neurodevelopment at 2 Years’ Corrected Age: Follow-Up of a Double-Blind, Placebo-Controlled, Multicentre, Randomised Trial

Autor: Nienke M. Halbmeijer, Wes Onland, Filip Cools, Renate Swarte, Marja van der Heide-Jalving, Maruschka P. Merkus, Peter H. Dijk, Susanne Mulder-de Tollenaer, Ratna Tan, Thilo Mohns, Els Bruneel, Arno F. van Heijst, Boris W. Kramer, Anne Debeer, Mirjam M. van Weissenbruch, Yoann Marechal, Henry Blom, Katleen Plaskie, Martin Offringa, Aleid G. van Wassenaer-Leemhuis, Anton H.L.C. van Kaam, SToP-BPD Study Group

Publikováno v: SSRN Electronic Journal.

Background: Our double-blind, placebo-controlled, randomised trial investigating systemic hydrocortisone in mechanically ventilated preterm infants (gestational age

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::60fd7985ded430a742cfbcf653f03d6c
https://doi.org/10.2139/ssrn.3745187

Retrospective study shows that doxapram therapy avoided the need for endotracheal intubation in most premature neonates

Autor: Sinno H.P. Simons, Monique van Dijk, Irwin K M Reiss, Nienke M. Halbmeijer, Naomi J. Meesters, Robert B. Flint, Joost van Rosmalen

Publikováno v: Acta Paediatrica, 106(5), 733-739. Wiley-Blackwell
Acta Paediatrica, 106, 733-739
Acta Paediatrica, 106, 5, pp. 733-739

Contains fulltext : 174442.pdf (Publisher’s version ) (Closed access) AIM: Using doxapram to treat neonates with apnoea of prematurity might avoid the need for endotracheal intubation and invasive ventilation. We studied whether doxapram prevented

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb666082cc138e315d7cf1139420b93d
https://pubmed.ncbi.nlm.nih.gov/28130789